These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 17389011)

  • 1. The duplicitous effects of interleukin 4 on tumour immunity: how can the same cytokine improve or impair control of tumour growth?
    Olver S; Apte S; Baz A; Kienzle N
    Tissue Antigens; 2007 Apr; 69(4):293-8. PubMed ID: 17389011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-derived interleukin-4 reduces tumor clearance and deviates the cytokine and granzyme profile of tumor-induced CD8+ T cells.
    Olver S; Groves P; Buttigieg K; Morris ES; Janas ML; Kelso A; Kienzle N
    Cancer Res; 2006 Jan; 66(1):571-80. PubMed ID: 16397274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dendritic cell activation by combined exposure to anti-CD40 plus interleukin (IL)-12 and IL-18 efficiently stimulates anti-tumor immunity.
    Balkow S; Loser K; Krummen M; Higuchi T; Rothoeft T; Apelt J; Tuettenberg A; Weishaupt C; Beissert S; Grabbe S
    Exp Dermatol; 2009 Jan; 18(1):78-87. PubMed ID: 19054060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-23 promotes tumour incidence and growth.
    Langowski JL; Zhang X; Wu L; Mattson JD; Chen T; Smith K; Basham B; McClanahan T; Kastelein RA; Oft M
    Nature; 2006 Jul; 442(7101):461-5. PubMed ID: 16688182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer immunotherapy by interleukin-21: potential treatment strategies evaluated in a mathematical model.
    Cappuccio A; Elishmereni M; Agur Z
    Cancer Res; 2006 Jul; 66(14):7293-300. PubMed ID: 16849579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous IL-21 restricts CD8+ T cell expansion and is not required for tumor immunity.
    Søndergaard H; Coquet JM; Uldrich AP; McLaughlin N; Godfrey DI; Sivakumar PV; Skak K; Smyth MJ
    J Immunol; 2009 Dec; 183(11):7326-36. PubMed ID: 19915059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Memory T cells in cancer immunotherapy: which CD8 T-cell population provides the best protection against tumours?
    Perret R; Ronchese F
    Tissue Antigens; 2008 Sep; 72(3):187-94. PubMed ID: 18627571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allogeneic GM-CSF-secreting tumor cell immunotherapies generate potent anti-tumor responses comparable to autologous tumor cell immunotherapies.
    Li B; Simmons A; Du T; Lin C; Moskalenko M; Gonzalez-Edick M; VanRoey M; Jooss K
    Clin Immunol; 2009 Nov; 133(2):184-97. PubMed ID: 19664962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TLR ligand suppression or enhancement of Treg cells? A double-edged sword in immunity to tumours.
    Conroy H; Marshall NA; Mills KH
    Oncogene; 2008 Jan; 27(2):168-80. PubMed ID: 18176598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ampligen: a potential toll-like 3 receptor adjuvant for immunotherapy of cancer.
    Jasani B; Navabi H; Adams M
    Vaccine; 2009 May; 27(25-26):3401-4. PubMed ID: 19200817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-21 and IL-15 cytokine DNA augments HSV specific effector and memory CD8+ T cell response.
    Rodrigues L; Nandakumar S; Bonorino C; Rouse BT; Kumaraguru U
    Mol Immunol; 2009 Apr; 46(7):1494-504. PubMed ID: 19233474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracerebral interleukin 12 induces glioma rejection in the brain predominantly by CD8+ T cells and independently of interferon-gamma.
    Vetter M; Hofer MJ; Roth E; Pircher HP; Pagenstecher A
    J Neuropathol Exp Neurol; 2009 May; 68(5):525-34. PubMed ID: 19525900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Th2-mediated anti-tumour immunity: friend or foe?
    Ellyard JI; Simson L; Parish CR
    Tissue Antigens; 2007 Jul; 70(1):1-11. PubMed ID: 17559575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ag-specific type 1 CD8 effector cells enhance methotrexate-mediated antitumor responses by modulating endogenous CD49b-expressing CD4 and CD8 T effector cell subpopulations producing IL-10.
    Dobrzanski MJ; Reome JB; Hylind JC; Rewers-Felkins KA; Abdulsamad K; Adams SL
    Immunol Invest; 2008; 37(4):315-38. PubMed ID: 18569073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigen-nonspecific activation of CD8+ T lymphocytes by cytokines: relevance to immunity, autoimmunity, and cancer.
    Ramanathan S; Gagnon J; Ilangumaran S
    Arch Immunol Ther Exp (Warsz); 2008; 56(5):311-23. PubMed ID: 18836862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic immune response induced by intratumoral expression of the fusogenic membrane protein of vesicular stomatitis virus and cytokines encoded by adenoviral vectors.
    Hoffmann D; Bayer W; Wildner O
    Int J Mol Med; 2007 Nov; 20(5):673-81. PubMed ID: 17912460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokine, chemokine, and co-stimulatory fusion proteins for the immunotherapy of solid tumors.
    Khawli LA; Hu P; Epstein AL
    Handb Exp Pharmacol; 2008; (181):291-328. PubMed ID: 18071951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. alpha-fetoprotein and interleukin-18 gene-modified dendritic cells effectively stimulate specific type-1 CD4- and CD8-mediated T-Cell response from hepatocellular carcinoma patients in Vitro.
    Cao DY; Yang JY; Dou KF; Ma LY; Teng ZH
    Hum Immunol; 2007 May; 68(5):334-41. PubMed ID: 17462500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Basophils can directly present or cross-present antigen to CD8 lymphocytes and alter CD8 T cell differentiation into IL-10-producing phenotypes.
    Kim S; Shen T; Min B
    J Immunol; 2009 Sep; 183(5):3033-9. PubMed ID: 19667092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineered CD8+ cytotoxic T cells with fiber-modified adenovirus-mediated TNF-alpha gene transfection counteract immunosuppressive interleukin-10-secreting lung metastasis and solid tumors.
    Ye Z; Shi M; Chan T; Sas S; Xu S; Xiang J
    Cancer Gene Ther; 2007 Jul; 14(7):661-75. PubMed ID: 17479109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.